The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review

BACKGROUND: Lenvatinib combined with programmed cell death protein-1 inhibitor has achieved good survival results in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) has attracted attent...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuanren, Gao, Yin, Linan, Liu, Ruibao, Cui, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034403/
https://www.ncbi.nlm.nih.gov/pubmed/36969065
http://dx.doi.org/10.3389/fonc.2023.1054072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034403/
https://www.ncbi.nlm.nih.gov/pubmed/36969065
http://dx.doi.org/10.3389/fonc.2023.1054072

Ejemplares similares